NantHealth, Inc. (NH)
| Previous close | 3.7100 |
| Open | 3.7300 |
| Bid | 0.0000 x 1100 |
| Ask | 0.0000 x 3100 |
| Day's range | 3.6100 - 3.9400 |
| 52-week range | 1.5700 - 15.7500 |
| Volume | |
| Avg. volume | 110,061 |
| Market cap | 28.75M |
| Beta (5Y monthly) | 1.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.5100 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 60.00 |
- Business Wire
NantHealth Announces 1-for-15 Reverse Stock Split
MORRISVILLE, N.C., December 15, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company has implemented a reverse stock split at a ratio of 1-for-15, which is expected to be effective 5 p.m. Eastern Time (ET) on December 15, 2022. The company’s common stock is expected to begin trading on a split-adjusted basis at commencement of trading on Friday, December 16, 2022.
- Simply Wall St.
NantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)
NantHealth ( NASDAQ:NH ) Third Quarter 2022 Results Key Financial Results Revenue: US$16.6m (up 16% from 3Q 2021). Net...
- Business Wire
NantHealth Reports 2022 Third Quarter Financial Results
MORRISVILLE, N.C., November 03, 2022--NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2022.
